GeneTether Therapeutics Inc.

    GeneTether Therapeutics Inc.

    CCSE:GTTX
    - -
    CAD
    - -
    - -
    GeneTether Therapeutics Inc.
    CSE:GTTX
    (Canadian Securities Exchange)

    Recent

    price

    - -

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2020
    2021
    2022
    2023
    TTM
    USD
    - -
    - -
    - -
    - -
    - -
    Revenue per Share
    - -
    -0.04
    -0.04
    -0.01
    -0.02
    Basic EPS, GAAP
    - -
    -0.02
    -0.03
    -0.01
    -0.01
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    - -
    -0.01
    0.01
    - -
    -0.01
    Book Value per Share
    - -
    - -
    0.04
    0.03
    0.03
    Tangible Book Value per Share
    46
    46
    43
    46
    39
    Basic Weighted Avg Shares
    - -
    - -
    - -
    - -
    - -
    Sales/Revenue/Turnover
    - -
    - -
    - -
    - -
    - -
    Operating Margin (%)
    - -
    - -
    - -
    - -
    - -
    Depreciation Expense
    - -
    -2
    -2
    -1
    -1
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    - -
    - -
    2
    1
    1
    Working Capital
    - -
    - -
    - -
    - -
    - -
    LT Debt
    - -
    - -
    2
    1
    1
    Total Equity
    - -
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)

    Capital Structure

    USD

    •

    in mil. unless spec.
    Mar'24
    Jun'24
    Sep'24
    ST Debt
    - -
    - -
    - -
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    39
    39
    39
    Market Capitalization
    1
    2
    - -

    Working Capital

    USD

    •

    in mil. unless spec.
    Mar'24
    Jun'24
    Sep'24
    Total Current Assets
    1
    1
    1
    Cash, Cash Equivalents & STI
    1
    1
    1
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    - -
    - -
    - -
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    - -
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    - -
    -26.09%
    Free Cash Flow
    - -
    - -
    -60.53%
    Net Income, GAAP
    - -
    - -
    -59.87%
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    -0.01
    -0.01
    -0.01
    - -
    -0.04
    2023
    - -
    - -
    - -
    - -
    -0.01
    2024
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business